Edward S. Kim, MD, FACP, MBA

A Phase 3 Non-Inferiority Study Comparing Paliperidone Palmitate 1-Month vs 3-Month Long-Acting Injectables for Negative Symptom Improvement in Schizophrenia

Background: Negative symptoms of schizophrenia are predictors of long-term disability. Paliperidone palmitate 3-month formulation (PP3M) provides a sustained release of paliperidone, perm...

Edward S. Kim , MD, FACP, MBA;

Arun K. Singh , MD, PhD, MCh, MNAMS;

Katalin Pungor , PhD;

Maju Mathews , MD;

Jagadish Gogate , PhD;

Srihari Gopal , MD;

03/01/2019

From the Field

A Novel Clinical Pathways Approach to Delivering Regional-Based Clinical Trials and Patient Care in a Hybrid Academic-Community-Based System

05/15/2018

Kathryn E, Patronik , MHA;

Edward S. Kim , MD, FACP, MBA;

Abstract: The health care landscape is becoming constantly more complex with new drug treatments and molecular testing. In order to achieve consistent, up-to-date patient care, clinical pathways are becoming...

...

05/15/2018

Journal of Clinical Pathways

Outside Your IO Comfort Zone Case #5: Off-Label Use of Therasphere to Treat an 84-Year-Old Man With Cholangiocarcinoma

Edward Kim, MD, Associate Professor of Radiology and Surgery, Mount Sinai Health System, Icahn School of Medicine at Mount Sinai presents case #5 from "Outside Your IO Comfort Zone: Learn...

Edward S. Kim , MD, FACP, MBA;

07/28/2021

Y-90: My Top 5 Tips and Tricks

Edward Kim, MD, Associate Professor of Radiology and Surgery, Mount Sinai Health System, Icahn School of Medicine at Mount Sinai, offers his top 5 tips and tricks for Y-90 radioembolizati...

Edward S. Kim , MD, FACP, MBA;

07/28/2021